Search

PHARMACOLOGICAL TREATMENT OF PARKINSON’S DISEASE: MOLECULAR ASPECTS AND PROSPECTS

Paltsev M.A., Zuev V.A., Diatlova A.S., Linkova N.S., Kvetnaia T.V.

Parkinson’s disease (PD) is a progressive, age-related, neuronal disorder that affects as much as 1% of the persons over 65 years. According to forecasts of the World Health Organization over the world about 9 million people will suffer from PD by 2030. So PD …